hotspot -WSS

hotspot

author：Wikipedia 2025-09-07 14:01:28 - browse：3885

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Bispecific antibodies are next new thing in cancer immunotherapy

WSS

With Roe v Wade overturned, abortion providers work to adapt

Lawsuit highlights wrinkle for disputes over surprise medical bills

Millions may soon lose Medicaid when they don't have to

RSV injection headlines need to be accurate for good uptake

Biden administration plans revamp of organ transplant system

Novo: Oral version of Ozempic leads to 15% weight loss

hotspot

hotspot

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

CDC picks Alphabet's Verily for wasterwater surveillance contract

Supreme Court strikes down use of affirmative action

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Sports medicine is finally prioritizing gender equality

Inside the rise of 'mukbang' eating videos

At least 13 dead in Texas as scorching temps continue

Inside the rise of 'mukbang' eating videos

In age of alternative facts, a scholarly course on calling out crap

Novo: Oral version of Ozempic leads to 15% weight loss

entertainment

The biotech scorecard for Q4: 16 stock

Biogen nominates mother of director’s child to replace him on board

With Roe v Wade overturned, abortion providers work to adapt

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

6 solutions to address cancer drug shortages and others

Living organ donors deserve priority status for transplants

focus

entertainment

entertainment

hotspot